Abstract Library

#1306 The Role of Ga68-DOTATOC-PET-CT in Routine Screening of Multiple Endocrine Neoplasia Type 1

Introduction: Multiple endocrine neoplasia type 1 is a tumor syndrome characterized by NENs of the pancreas, duodenum, parathyroid, pituitary, adrenal, thymus and bronchi. Gene carriers are recommended participation in prospective screening programs at expert centers. Ga68-DOTATOC-PET-CT is an increasingly used very sensitive imaging technique for GEP-NENs.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Albers M, Lopez C, Manoharan J, Bartsch D,

Keywords: MEN1, Ga68-DOTATOC-PET, screening,

#679 Malignant Pheocromocytoma: Rare, Aggressive, but Easily Neglected

Introduction: Pheocromocytomas are rare neuroendocrine tumors of which only 10% present metastatic disease.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Ribeiro C

Authors: Ribeiro C, Patrício C, Gaspar C, Pereira R, Silva F,

Keywords: malignant pheocromocytoma, cyanosis, methanephrines, adrenergic crisis ,

#111 Atypical lung carcinoid tumor metastatic to endocrine glands and bone marrow

Introduction: Bronchopulmonary neuroendocrine tumors (BP-NETs) comprise 20% of all lung cancers. Typical low grade carcinoid tumors (TC) represent the majority of BP-carcinoids. Intermediate grade atypical carcinoid tumors (AC) are less often encountered but more aggressive. Although metastatic dissemination to mediastinal lymph nodes, liver, skeleton and central nervous system (CNS) is common, involvement of the endocrine glands has rarely been reported.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Daraki V, Agelaki S, Milaki G, Mamalaki E, Georgoulias V,

Keywords: atypical carcinoid tumor, lung, multiple metastases, pituitary, adrenal, bone,

#56 Somatostatinreceptor scintigraphy with Tc-99m-tektrotyd in patients with neuroendocrine tumors: correlation with immunohistochemistry

Introduction: Somatostatin receptor scintigraphy (STRS) with Tc-99m-tektrotyd has been used in the past few years for diagnosis and staging of neuroendocrine tumors (NETs). A number of clinicopathologic criteria proved to be useful predictors of malignant behavior of these tumors. Immunohistochemical markers for NETs include cell proliferation (Ki-67 index) and neuroendocrine markers such as chromogranin A (CgA) and synaptophysin.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Rodrigues M

Authors: Rodrigues M, Mirzaei S, Glaser K, Pokieser W,

Keywords: immunohistochemistry, Ki-67, CgA, synaptophysin, somatostatinreceptor scintigraphy, neuroendocrine tumours ,

#54 The clinical challenge of patients with a thoracic or neck neuroendocrine tumor: a retrospective analysis from a single Irish institution

Introduction: Thoracic and neck neuroendocrine tumors (T-N-NETs) represent a rare and intriguing condition and the management of patients with a NET localized at the thorax or neck can be extremely problematic. An expert and multidisciplinary approach is generally required for the optimal management of NET patients. A systematic multidisciplinary approach to NET patients has been recently established at our institution.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Tamagno G, McGowan L, Phelan S, Sheahan K, O’Shea D,

Keywords: neuroendocrine tumor, thorax, neck, multidisciplinary approach, patient care,